Insulin glargine/ja: Difference between revisions
Insulin glargine/ja
Created page with "<!-- Definition and medical uses --> '''ランタス'''などの商品名で販売されている'''インスリングラルギン'''は、医療用インスリンの長時間作用型改良型であり、Ⅰ型糖尿病および2型糖尿病の管理に用いられる。皮膚のすぐ下に注射する。効果は一般に使用後1時間で始ま..." Tags: Mobile edit Mobile web edit |
Created page with "{{DEFAULTSORT:Insulin Glargine}} Category:Insulin receptor agonists Category:Human proteins Category:Recombinant proteins Category:Peptide hormones Category:Peptide therapeutics Category:Wikipedia medicine articles ready to translate Category:Drugs developed by Eli Lilly and Company Category:Drugs developed by Boehringer Ingelheim Category:Sanofi Category:World Health Organization essential medicines" |
||
| Line 188: | Line 188: | ||
</div> | </div> | ||
{{Oral hypoglycemics and insulin analogs}} | {{Oral hypoglycemics and insulin analogs}} | ||
{{Eli Lilly and Company}} | {{Eli Lilly and Company/ja}} | ||
{{Portal bar | Medicine}} | {{Portal bar | Medicine}} | ||
{{DEFAULTSORT:Insulin Glargine}} | {{DEFAULTSORT:Insulin Glargine}} | ||
[[Category:Insulin receptor agonists]] | [[Category:Insulin receptor agonists]] | ||
| Line 207: | Line 203: | ||
[[Category:Sanofi]] | [[Category:Sanofi]] | ||
[[Category:World Health Organization essential medicines]] | [[Category:World Health Organization essential medicines]] | ||